You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Litigation Details for Adverio Pharma GmbH v. MSN Laboratories Private Limited (D. Del. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Adverio Pharma GmbH v. MSN Laboratories Private Limited
The small molecule drug covered by the patent cited in this case is ⤷  Try a Trial .

Details for Adverio Pharma GmbH v. MSN Laboratories Private Limited (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-01-08 1 action for patent infringement by Alembic of U.S. Patent No. 6,743,798 (“the ’798 Patent”), arising … 2004, the United States Patent and Trademark Office issued the ’798 Patent, entitled “Substituted Pyrazole…claimed in the ’798 Patent. 30. Adverio is the assignee of the ’798 Patent and holds title to…to the ’798 Patent. 31. Bayer AG is the exclusive licensee of the ’798 Patent in the United…798 Patent is listed in the Orange Book in association with Adempas®. The ’798 Patent claims External link to document
2018-04-03 16 action for patent infringement alleging infringement of U.S. Patent No. 6,743,798 (the “‘798 Patent”). At …manufactured under the ‘798 Patent, prior to expiration of the ‘798 Patent. Plaintiffs filed their… sale of a drug claimed in a patent before the expiration of the patent at issue. By making the act of…plaintiffs’ patents. Plaintiffs sought declaratory relief that the defendants had infringed the patents-in-suit… Mylan Pharms. Inc. (In re Rosuvastatin Calcium Patent Litig.), 2008 U.S. Dist. LEXIS 96289 (D. Del. Nov External link to document
2018-01-08 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,743,798 B1;. (sar) (Entered… 21 December 2020 1:18-cv-00073 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2019-02-12 71 have legal rights in U.S. Patent No. 6,743 ,798 (the "' 798 patent"), entitled "Substituted…product would not infringe the ' 798 patent and that the patent is invalid. (Id. 138; see also 21 U.S.C…pre-launch resolution of patent disputes between the parties with interests in the patents protecting a branded…quot;) prior to the expiration of the ' 798 patent. (Id. 11 1, 9, 10) Accordingly, Alembic has…Adverio Pharma is the assignee of the ' 798 patent and Bayer AG is the exclusive licensee in the United External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.